Zhou X - Search Results

1

Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria.

Zhang Y, Zhang D, Zhao W, Li H, Lu Z, Guo B, Meng X, Zhou X, Yang Y. Zhang Y, et al. Among authors: zhou x. J Med Chem. 2024 Apr 25;67(8):6585-6609. doi: 10.1021/acs.jmedchem.4c00018. Epub 2024 Apr 10. J Med Chem. 2024. PMID: 38598362

2

Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents.

Ding S, Dai RY, Wang WK, Cao Q, Lan LF, Zhou XL, Yang YS. Ding S, et al. Bioorg Med Chem Lett. 2018 Jan 15;28(2):94-102. doi: 10.1016/j.bmcl.2017.12.005. Epub 2017 Dec 5. Bioorg Med Chem Lett. 2018. PMID: 29233653

3

Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles.

Guo B, Guo S, Huang J, Li J, Li J, Chen Q, Zhou X, Xie X, Yang Y. Guo B, et al. Among authors: zhou x. Bioorg Med Chem. 2018 Dec 1;26(22):5780-5791. doi: 10.1016/j.bmc.2018.10.019. Epub 2018 Oct 22. Bioorg Med Chem. 2018. PMID: 30392954

4

Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria.

Shi C, Zhang Y, Wang T, Lu W, Zhang S, Guo B, Chen Q, Luo C, Zhou X, Yang Y. Shi C, et al. Among authors: zhou x. J Med Chem. 2019 Mar 28;62(6):2950-2973. doi: 10.1021/acs.jmedchem.8b01750. Epub 2019 Mar 6. J Med Chem. 2019. PMID: 30698430

5

Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.

Zhao S, Zhen Y, Fu L, Gao F, Zhou X, Huang S, Zhang L. Zhao S, et al. Among authors: zhou x. Bioorg Med Chem Lett. 2019 Oct 1;29(19):126623. doi: 10.1016/j.bmcl.2019.126623. Epub 2019 Aug 14. Bioorg Med Chem Lett. 2019. PMID: 31439379

6

Design, synthesis, and biological evaluation of low-toxic lappaconitine derivatives as potential analgesics.

Li Y, Shang Y, Li X, Zhang Y, Xie J, Chen L, Gao F, Zhou XL. Li Y, et al. Among authors: zhou xl. Eur J Med Chem. 2022 Dec 5;243:114776. doi: 10.1016/j.ejmech.2022.114776. Epub 2022 Sep 17. Eur J Med Chem. 2022. PMID: 36162215

7

In vitro and in vivo biological evaluation of Lappaconitine derivatives as potential anti-inflammatory agents.

Xiao Y, Han M, Chen Y, Li YZ, Zhang YY, Chen L, Huang S, Zhou XL. Xiao Y, et al. Chem Biodivers. 2024 Feb;21(2):e202301761. doi: 10.1002/cbdv.202301761. Epub 2024 Jan 5. Chem Biodivers. 2024. PMID: 38117633

8

Recent advances in microtubule-stabilizing agents.

Cao YN, Zheng LL, Wang D, Liang XX, Gao F, Zhou XL. Cao YN, et al. Eur J Med Chem. 2018 Jan 1;143:806-828. doi: 10.1016/j.ejmech.2017.11.062. Epub 2017 Nov 24. Eur J Med Chem. 2018. PMID: 29223097 Review.

9

Natural products as important tyrosine kinase inhibitors.

Yin B, Fang DM, Zhou XL, Gao F. Yin B, et al. Eur J Med Chem. 2019 Nov 15;182:111664. doi: 10.1016/j.ejmech.2019.111664. Epub 2019 Aug 30. Eur J Med Chem. 2019. PMID: 31494475 Review.

10

Synthesis and biological evaluation of lycoctonine derivatives with cardiotonic and calcium channels inhibitory activities.

Wang JZ, Li XY, Zhang M, Xiao Y, Chen L, Deng MY, Huang S, Zhou XL. Wang JZ, et al. Bioorg Chem. 2024 May;146:107297. doi: 10.1016/j.bioorg.2024.107297. Epub 2024 Mar 16. Bioorg Chem. 2024. PMID: 38503027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49,336 results

Search Page